Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies
Identifieur interne : 000C75 ( Main/Merge ); précédent : 000C74; suivant : 000C76Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies
Auteurs : Barbara Kaiser-Mccaw Hecht [États-Unis] ; Alan L. Epstein [États-Unis] ; Carol S. Berger [États-Unis] ; Henry S. Kaplan [États-Unis] ; Frederick Hecht [États-Unis]Source :
- Cancer Genetics and Cytogenetics [ 0165-4608 ] ; 1984.
English descriptors
- Teeft :
- Abnormality, Biomedical research institute, Cell line, Cell lines, Cell lymphomas, Cell type, Chain genes, Chromosomal, Chromosome, Cytogenetic, Cytogenetic studies, Diffuse, Diffuse histiocytic, Epstein, Hecht, Histiocytic, Histiocytic lymphoma cell lines, Human chromosomes, Human immunoglobulin, Immunoglobulin, Intermediate grade, Kaplan, Karyotype, Large cell, Large cell immunoblastic, Leukemia, Lymphocytic, Lymphoma, Lymphoma cell lines, Malignant, Malignant lymphoma, Malignant lymphomas, Marker chromosome, Null cell, Oncogene, Proc natl acad, Rearrangement, Translocation.
Abstract
Abstract: Cell lines were established from 15 patients with diffuse histiocytic lymphoma (DHL) of the intermediate grade, diffuse large cell (class G), and high-grade, large cell immunoblastic (class H) types. Immunologic studies indicated that 11 of the 15 DHL cell lines were B cell in origin, 2 were histiocytic, and 2 were null cell. Cytogenetic studies revealed 1 hypodiploid, 11 hyperdiploid, and 3 near-tetraploid cell lines. Chromosome #7 was trisomic in 3 lines, chromosomes #12 in 4 lines, and chromosome #13 in 3 lines. Chromosome #2 was monosomic in 3 lines, chromosome #8 was monosomic in 5 lines, chromosome #14 in 4 lines, and chromosome #22 in 6 cell lines. This is of special interest, as chromosomes #2, #8, #14, and #22 are clearly concerned with rearrangements in Burkitt's lymphoma and immunoglobulin expression. The most common rearrangement in the DHL cell lines involved chromosome #14 at band 14q32. However, in contrast to Burkitt's lymphoma, the pattern of translocation in DHL is between chromosome #14 and usually chromosome #11 or chromosome #18. The 14;18 translocation is not restricted to patients with low-grade follicular, small cleaved cell lymphomas, as has been reported. The 14q+ chromosome is characteristic of lymphoid malignancies in general. It is due, invariably, to a translocation with the breakpoint in band 14q32, which is the locus of the immunoglobulin heavy chain genes. We propose that in each translocation, for example, chromosomes #11 or #18, an oncogene may be transposed onto chromosome #14, and that each 14q+ translocation in DHL represents an event that transposes an oncogene from another chromosome to chromosome #14.
Url:
DOI: 10.1016/0165-4608(85)90186-4
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000874
- to stream Istex, to step Curation: 000873
- to stream Istex, to step Checkpoint: 000933
Links to Exploration step
ISTEX:6473D2AA67B2D7B908E7412174A4A224DBE56489Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies</title>
<author><name sortKey="Hecht, Barbara Kaiser Mccaw" sort="Hecht, Barbara Kaiser Mccaw" uniqKey="Hecht B" first="Barbara Kaiser-Mccaw" last="Hecht">Barbara Kaiser-Mccaw Hecht</name>
</author>
<author><name sortKey="Epstein, Alan L" sort="Epstein, Alan L" uniqKey="Epstein A" first="Alan L." last="Epstein">Alan L. Epstein</name>
</author>
<author><name sortKey="Berger, Carol S" sort="Berger, Carol S" uniqKey="Berger C" first="Carol S." last="Berger">Carol S. Berger</name>
</author>
<author><name sortKey="Kaplan, Henry S" sort="Kaplan, Henry S" uniqKey="Kaplan H" first="Henry S." last="Kaplan">Henry S. Kaplan</name>
</author>
<author><name sortKey="Hecht, Frederick" sort="Hecht, Frederick" uniqKey="Hecht F" first="Frederick" last="Hecht">Frederick Hecht</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6473D2AA67B2D7B908E7412174A4A224DBE56489</idno>
<date when="1984" year="1984">1984</date>
<idno type="doi">10.1016/0165-4608(85)90186-4</idno>
<idno type="url">https://api.istex.fr/document/6473D2AA67B2D7B908E7412174A4A224DBE56489/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000874</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000874</idno>
<idno type="wicri:Area/Istex/Curation">000873</idno>
<idno type="wicri:Area/Istex/Checkpoint">000933</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000933</idno>
<idno type="wicri:doubleKey">0165-4608:1984:Hecht B:histiocytic:lymphoma:cell</idno>
<idno type="wicri:Area/Main/Merge">000C75</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies</title>
<author><name sortKey="Hecht, Barbara Kaiser Mccaw" sort="Hecht, Barbara Kaiser Mccaw" uniqKey="Hecht B" first="Barbara Kaiser-Mccaw" last="Hecht">Barbara Kaiser-Mccaw Hecht</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ</wicri:regionArea>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Epstein, Alan L" sort="Epstein, Alan L" uniqKey="Epstein A" first="Alan L." last="Epstein">Alan L. Epstein</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Northwestern University, Chicago, IL</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Berger, Carol S" sort="Berger, Carol S" uniqKey="Berger C" first="Carol S." last="Berger">Carol S. Berger</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ</wicri:regionArea>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kaplan, Henry S" sort="Kaplan, Henry S" uniqKey="Kaplan H" first="Henry S." last="Kaplan">Henry S. Kaplan</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Biology Research Laboratory, Stanford University School of Medicine, Stanford, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hecht, Frederick" sort="Hecht, Frederick" uniqKey="Hecht F" first="Frederick" last="Hecht">Frederick Hecht</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ</wicri:regionArea>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Cancer Genetics and Cytogenetics</title>
<title level="j" type="abbrev">CGC</title>
<idno type="ISSN">0165-4608</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1984">1984</date>
<biblScope unit="volume">14</biblScope>
<biblScope unit="issue">3–4</biblScope>
<biblScope unit="page" from="205">205</biblScope>
<biblScope unit="page" to="218">218</biblScope>
</imprint>
<idno type="ISSN">0165-4608</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0165-4608</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abnormality</term>
<term>Biomedical research institute</term>
<term>Cell line</term>
<term>Cell lines</term>
<term>Cell lymphomas</term>
<term>Cell type</term>
<term>Chain genes</term>
<term>Chromosomal</term>
<term>Chromosome</term>
<term>Cytogenetic</term>
<term>Cytogenetic studies</term>
<term>Diffuse</term>
<term>Diffuse histiocytic</term>
<term>Epstein</term>
<term>Hecht</term>
<term>Histiocytic</term>
<term>Histiocytic lymphoma cell lines</term>
<term>Human chromosomes</term>
<term>Human immunoglobulin</term>
<term>Immunoglobulin</term>
<term>Intermediate grade</term>
<term>Kaplan</term>
<term>Karyotype</term>
<term>Large cell</term>
<term>Large cell immunoblastic</term>
<term>Leukemia</term>
<term>Lymphocytic</term>
<term>Lymphoma</term>
<term>Lymphoma cell lines</term>
<term>Malignant</term>
<term>Malignant lymphoma</term>
<term>Malignant lymphomas</term>
<term>Marker chromosome</term>
<term>Null cell</term>
<term>Oncogene</term>
<term>Proc natl acad</term>
<term>Rearrangement</term>
<term>Translocation</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: Cell lines were established from 15 patients with diffuse histiocytic lymphoma (DHL) of the intermediate grade, diffuse large cell (class G), and high-grade, large cell immunoblastic (class H) types. Immunologic studies indicated that 11 of the 15 DHL cell lines were B cell in origin, 2 were histiocytic, and 2 were null cell. Cytogenetic studies revealed 1 hypodiploid, 11 hyperdiploid, and 3 near-tetraploid cell lines. Chromosome #7 was trisomic in 3 lines, chromosomes #12 in 4 lines, and chromosome #13 in 3 lines. Chromosome #2 was monosomic in 3 lines, chromosome #8 was monosomic in 5 lines, chromosome #14 in 4 lines, and chromosome #22 in 6 cell lines. This is of special interest, as chromosomes #2, #8, #14, and #22 are clearly concerned with rearrangements in Burkitt's lymphoma and immunoglobulin expression. The most common rearrangement in the DHL cell lines involved chromosome #14 at band 14q32. However, in contrast to Burkitt's lymphoma, the pattern of translocation in DHL is between chromosome #14 and usually chromosome #11 or chromosome #18. The 14;18 translocation is not restricted to patients with low-grade follicular, small cleaved cell lymphomas, as has been reported. The 14q+ chromosome is characteristic of lymphoid malignancies in general. It is due, invariably, to a translocation with the breakpoint in band 14q32, which is the locus of the immunoglobulin heavy chain genes. We propose that in each translocation, for example, chromosomes #11 or #18, an oncogene may be transposed onto chromosome #14, and that each 14q+ translocation in DHL represents an event that transposes an oncogene from another chromosome to chromosome #14.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/BernheimV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C75 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000C75 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Psychologie |area= BernheimV1 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:6473D2AA67B2D7B908E7412174A4A224DBE56489 |texte= Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies }}
This area was generated with Dilib version V0.6.33. |